Management of Essential Hypertension with Ayurvedic Herbal Medicines and its computational analysis
Phase 2
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2024/07/070973
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of Essential Hypertension / Stage I Hypertension.
2.Patients between the age group of 30-65 years.
3.Patients suffering from Stage I Hypertension.
Exclusion Criteria
1.Patients of Secondary Hypertension.
2.patients with any other comorbities e.g. Diabetes Mellitus, thyroid disorders, CCF, Multiorgan failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the In-silico binding of Drug ligands on Protein Aminopeptidase A by the process of Molecular Docking.To assess the efficacy of selected compounds on the patients of Essential Hypertension.To assess the efficacy of Gomutra bhavit selected compounds on the patients of Essential Hypertension.To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 6weeks
- Secondary Outcome Measures
Name Time Method To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 3 month